The roles of matrix metalloproteinases-2, -7, -10 and tissue inhibitor of metalloproteinase-1 in the pathogenesis of oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 41, Issue 9, 2012, Pages 689-696

  Rubaci, Asli Hayirlioglu ^a   Kazancioglu, Hakki Oguz ^b   Olgac, Vakur ^c   Ak, Gulsum ^d  

^a MINISTRY OF HEALTH   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Matrix metalloproteinases; Oral lichen planus; Pathology; Tissue inhibitors of metalloproteinase 1

Indexed keywords

GELATINASE A; MATRILYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ALVEOLAR RIDGE; ARTICLE; CHEEK; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GINGIVA; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; LIP; MALE; MOUTH LICHEN PLANUS; PALATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN; TONGUE;

EID: 85027920724     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01160.x     Document Type: Article

References (32)

1. Torti DC, Jorizzo JL, McCarty MA. Oral lichen planus. Arch Dermatol 2007; 143: 511-5.
2. Brant JMC, Vasconcelos AC, Rodrigues LV. Role of apoptosis in erosive and reticular oral lichen planus exhibiting variable epithelial thickness. Braz Dent J 2008; 19: 179-85.
3. Boisnic S, Frances C, Branchet MC, Szpirglas H, Le Charpentier YL. Immunohistochemical study of oral lesions of lichen planus: diagnostic and pathophysiolojic aspects. Oral Surg Oral Med Oral Pathol 1990; 70: 462-5.
4. Eisen D. The clinical features, malignant potential and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-14.
5. Chainani-Wu N, Silverman S, Lozada-Nur F, Mayer P, Watson JJ. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 2001; 132: 901-9.
6. Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997; 106: 271-8.
7. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
8. Edwards PC, Kelsh R. Oral lichen Planus: clinical presentation and management. J Can Dent Assoc 2002; 68: 494-9.
9. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004; 10: 311-8.
10. Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 1993; 53: 4493.
11. Lin SC, Lo SS, Liu CJ, et al. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004; 33: 405-9.
12. Tilakaratne WM, Kobayashi T, Ida-Yonemochi H, et al. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers. J Oral Pathol Med 2009; 38: 348-55.
13. Yen CY, Chen CH, Chang CH, et al. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 2009; 14: 244-9.
14. Pradhan-Palikhe P, Vesterinen T, Tarkkanen J, et al. Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Oral Oncol 2010; 46: 514-8.
15. Singh RD, Haridas N, Patel JB, et al. Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem 2010; 25: 250-9.
16. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678.
17. Marcaccini AM, Meschiari CA, Zuardi LR, et al. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol 2010; 37: 180-90.
18. Cai H-X, Pan C-B, Li H-G. Expression of matrix metalloproteinases in cancerization of oral mucosa. Acad J SUMS 2002; 23: 477-9.
19. Giannelli G, Brassard J, Foti C, et al. Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B. Lab Invest 1996; 74: 1091.
20. Sutinen M, Kainulainen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998; 77: 2239.
21. Mazzarella N, Femiano F, Gombos F, De Rosa A, Giuliano M. Matrix metalloproteinase gene expression in oral lichen planus. J Eur Acad Dermatol Venereol 2006; 20: 953-7.
22. Chen Y, Zhang W, Geng N, Tian K, Windsor LJ. MMPs, TIMP-2, and TGF-b1 in the Cancerization of Oral Lichen Planus. Head Neck 2008; 30: 1237-45.
23. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 2001; 28: 72-82.
24. Uitto VJ, Overall CM, Mc Culloch C. Proteolytic host enzymes in gingival crevice fluid. Periodontol 2000 2003; 31: 77-104.
25. Chiang WC, Wong YK, Lin SC, Chang KW, Liu CJ. Increase of MMP-13 expression in multi stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Dis 2006; 12: 27-33.
26. Muller D, Wolf C, Abecassis J, et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993; 53: 165-9.
27. O-charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001; 127: 813-20.
28. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma: a clinicopathologic study. Am J Clin Pathol 1993; 99: 18-23.
29. Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinases- 2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995; 104: 678-84.
30. Ikebe T, Shinohara M, Takeuchi H, et al. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 1999; 17: 315-23.
31. Hong S-D, Hong S-P, Lee J-I, Lim C-Y. Expression of matrix metalloproteinase- 2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 2000; 36: 207-13.
32. Luukkaa H, Klemi P, Hirsimäki P, et al. Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol 2008; 128: 482-90.